Suppr超能文献

实验性结核病中小鼠体细胞对利福平的耐药性

Drug Resistance of Mouse Somatic Cells to Rifampicin in Experimental Tuberculosis.

作者信息

Nikonenko B V, Bocharova I V, Lepekha L N

机构信息

Central Research Institute for Tuberculosis, Moscow, Russia.

出版信息

Bull Exp Biol Med. 2021 May;171(1):53-55. doi: 10.1007/s10517-021-05171-x. Epub 2021 May 29.

Abstract

We have demonstrated that long-term exposure of intact mice to rifampicin (6 months) induces resistance to this drug, which manifested in inability of rifampicin to suppress the growth of Mycobacterium tuberculosis in the lungs and spleen during subsequent infection. It the same time, isoniazid is still effective in these mice. In this case, the phenomenon of somatic resistance to rifampicin in mice was observed if the treatment was started in a short period (within 4 days) after infection with M. tuberculosis. If the interval between infection and rifampicin administration was longer (3 weeks), the resistance disappeared.

摘要

我们已经证明,将完整的小鼠长期暴露于利福平(6个月)会诱导其对该药物产生抗性,这表现为在随后的感染过程中,利福平无法抑制肺和脾中结核分枝杆菌的生长。与此同时,异烟肼在这些小鼠中仍然有效。在这种情况下,如果在感染结核分枝杆菌后的短时间内(4天内)开始治疗,会观察到小鼠对利福平的体细胞抗性现象。如果感染与给予利福平之间的间隔更长(3周),则抗性消失。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验